FDA

The panel voted 8-6 despite agency scientists’ warnings that certain peptide chemicals lack evidence of safety or...

Patients with no other options are watching an agency turn on its own scientists — and the...

Bemotrizinol — already common in Mexico, Canada and South Korea — won FDA approval on June 9,...